Navigation Links
Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R)
Date:2/21/2008

for ONCONASE to simultaneously switch on and off numerous genes controlling major regulatory processes in the cell life cycle, and underscores that ONCONASE works selectively and does not appear to kill cells indiscriminately," added Kuslima Shogen, Alfacell's chief executive officer. "This research represents an important step forward in our continuing efforts to create targeted ONCONASE fusion proteins and to bring them forward into the clinic."

About ONCONASE(R)

ONCONASE is a first-in-class product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells while sparing normal cells. ONCONASE triggers apoptosis, the natural death of cells, via multiple molecular mechanisms of action.

About Alfacell Corporation

Alfacell Corporation is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE, is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. In addition to an ongoing Phase IIIb study in malignant mesothelioma, Alfacell is conducting a Phase I/II trial of

ONCONASE in non-small cell lung cancer (NSCLC) and other solid tumors. For more information, visit http://www.alfacell.com.

Safe Harbor

This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or c
'/>"/>

SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
4. Clinical Trial Participation Unaffected by Disclosure of Investigators Financial Stake, Food and Drug Law Journal Article Finds
5. Sexual Function Affected by Stem Cell Transplant According to Long-Term Study
6. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
7. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... Pa. , July 31, 2015 ... fully integrated specialty pharmaceutical company focused on developing, ... the closing of its previously announced underwritten public ... at a public offering price of $11.25 per ... offering included 1,000,000 shares issued upon the exercise ...
(Date:7/31/2015)... 31, 2015 Magnaquest, a ... data and cloud computing operators has signed a ... giant for Internet of Things (IoT) related initiative. ... on subscription model.      (Logo: ... striving for business innovations to make healthcare services ...
(Date:7/30/2015)... 30, 2015  ResMed Inc. (NYSE: RMD ) ... 2015.  Revenue for the quarter was $453.1 million, a ... 30, 2014 (a 17 percent increase on a constant ... the quarter ended June 30, 2014.  Diluted earnings per ... quarter ended June 30, 2014.  The ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16
... Stereotaxis, Inc. (Nasdaq: STXS ) today ... the Company its 100th patent, a major intellectual property ... the "Method and Apparatus for Dynamic Magnetic Field Control ... commitment to innovate and protect its leading position in ...
... Calif., Sept. 20 Questcor Pharmaceuticals, Inc. (Nasdaq: ... UBS Global Life Sciences Conference on Wednesday, September 22, 2010 ... Bailey, President and Chief Executive Officer, will discuss the Company,s ... Time. Attendance at this conference is by invitation ...
Cached Medicine Technology:Stereotaxis Achieves Intellectual Property Milestone With 100th U.S. Patent 2Stereotaxis Achieves Intellectual Property Milestone With 100th U.S. Patent 3Stereotaxis Achieves Intellectual Property Milestone With 100th U.S. Patent 4
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Girl Scouts ... out bullying across Georgia through the Girl Scout "Be a Friend First" program. Representatives ... Thursday, July 30. , “Peach State Health Plan and our parent company, Centene ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... The Mount ... on research projects that evaluate the potential of related, experimental treatments. The collaboration moves ... of Health to award Columbia Care one of five state licenses to produce and ...
(Date:7/31/2015)... ... July 31, 2015 , ... BioViva USA, Inc. (“BioViva”), a to-clinic ... aging diseases. , BioViva announces it has begun a fundraiser through Maximum Life ... (AD) and find a cure. MaxLife will grant 100% of the money raised to ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... the Northern District of Ohio, Western Division (Case No. 3:15-cv-00397) involving the ... the women experienced spontaneous migration of their Implanon® implants, inability to locate the ...
(Date:7/31/2015)... ... July 31, 2015 , ... The Heart Fit Clinic has increased a patient's ... heart rate of 150 beats versus 100 beats, this is a big deal," says ... give life back to patients with heart disease," he adds. People with angina are ...
Breaking Medicine News(10 mins):Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 3Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 3Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2
... measures, study finds , FRIDAY, Aug. 7 (HealthDay News) -- ... cancer have surgery to remove their breasts or ovaries in ... report. , Their study included 211 women, aged 35 to ... to increase the risk of breast and ovarian cancer. The ...
... , , WEST JORDAN, Utah, Aug. ... Jewish Community Center (JCC) the fourth annual Dannon Next Generation Nutrition Grant ... Lake County community. The JCC received $30,000 in support of its ... Fun, Fit & Healthy! will offer weekly, nutritionist-developed ...
... /PRNewswire-FirstCall/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: ... Chairman and Chief Executive Officer, will present at the upcoming ... will take place on Wednesday, August 12, 2009 at 11:00 ... About Transition, ----------------, , ...
... , , , , ... selected Artefill, the first and only FDA-approved microsphere-enhanced collagen filler for ... wrinkles. Kathleen Stegman, RN, M.A. has been an avid Artefill user ... for the long lasting correction of wrinkles. , , ...
... LAUDERDALE, Fla., Aug. 7 Averaging ... critical 24/7 patient information call center, Hospice Partners On Call ... secure colocation facility, to safeguard its powerful server infrastructure and ... Partners On Call decided to move their back-up servers to ...
... , DENVER, Aug. 7 An innovative program ... disease patients and teams of pharmacists, nurses, primary care doctors, and ... two years after they left the program by keeping them in ... by Kaiser Permanente published in The American Journal of Managed Care ...
Cached Medicine News:Health News:Many Opt for Surgery to Lower Breast, Ovarian Cancer Risk 2Health News:The Dannon Company Awards The I.J. & Jeanne Wagner Jewish Community Center the Fourth Annual Dannon Next Generation Nutrition Grant 2Health News:The Dannon Company Awards The I.J. & Jeanne Wagner Jewish Community Center the Fourth Annual Dannon Next Generation Nutrition Grant 3Health News:The Dannon Company Awards The I.J. & Jeanne Wagner Jewish Community Center the Fourth Annual Dannon Next Generation Nutrition Grant 4Health News:Transition Therapeutics to Present at Canaccord Adams 29th Annual Global Growth Conference 2Health News:Midwest Medical Aesthetics Helps Defy Nature and Wrinkles with Artefill 2Health News:Midwest Medical Aesthetics Helps Defy Nature and Wrinkles with Artefill 3Health News:Hospice Partners On Call Selects Category 5 Hurricane Rated 1Vault Networks to Safeguard Server and Call Center Infrastructure 2Health News:Electronic Health Records Help Cardiac Patients Remain Healthy 2Health News:Electronic Health Records Help Cardiac Patients Remain Healthy 3Health News:Electronic Health Records Help Cardiac Patients Remain Healthy 4
... Tamtron PowerPath is IMPACs comprehensive ... anatomic pathology laboratories to integrate and ... needs through a single, intuitive software ... more than 350 institutions have proven ...
The most compact revolutionary innovation in hematology. 8 or 18 automated parameter hematology analyzer....
... vision controls all refractor operations ... from the wireless remote control. ... can be loaded into the ... transfer. The illuminated LED heads-up ...
... in clinical color vision tests. It is ... or blue/yellow color vision losses that accompany ... Plaquenil, for example), early optic neuritis, glaucoma, ... is fast and accurate in quantifying congenital ...
Medicine Products: